$3.76
0.030.80%
Last update: 8:55 AM
15 minutes delayed
Comments
Loading...
Aileron Therapeutics (NASDAQ:ALRN) Stock, Earnings Estimates, EPS, And Revenue
Aileron Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Oct 11
EPS Estimate
$-0.410
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Aileron Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Aileron Therapeutics (ALRN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-14 | $-0.45 | $-0.42 | -7.14 % |
| Mar 2023 | 2023-05-08 | $-1.05 | $-0.86 | -22.1 % |
| Dec 2022 | 2023-03-20 | $-1.02 | $-1.36 | 25.0 % |
| Sep 2022 | 2022-11-01 | $-1.40 | $-1.60 | 12.5 % |
Aileron Therapeutics (ALRN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Aileron Therapeutics (NASDAQ:ALRN) reporting earnings?
Aileron Therapeutics (ALRN) is scheduled to report earnings on October 11, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
What were the latest earnings per share (EPS) for Aileron Therapeutics (NASDAQ:ALRN)?
The Actual EPS was $-0.45, which missed the estimate of $-0.42.
What were Aileron Therapeutics’s (NASDAQ:ALRN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.